Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection

Liver Transplantation

Volumn 18, Issue 6, 2012, Pages 716-726

  Terrault, Norah A ^a   Roland, Michelle E ^a   Schiano, Thomas ^b   Dove, Lorna ^c   Wong, Michael T ^d   Poordad, Fred ^e   Ragni, Margaret V ^f   Barin, Burc ^g   Simon, David ^h   Olthoff, Kim M ⁱ   Johnson, Lynt ^j   Stosor, Valentina ^k   Jayaweera, Dushyantha ^l   Fung, John ^m   Sherman, Kenneth E ⁿ   Subramanian, Aruna ^o   Millis, J Michael ^p   Slakey, Douglas ^q   Berg, Carl L ^r   Carlson, Laurie ^a   Ferrell, Linda ^a   Stablein, Donald M ^g   Odim, Jonah ^s   Fox, Lawrence ^s   Stock, Peter G ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g EMMES CORPORATION   (United States)

^h RUSH UNIVERSITY   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l UNIVERSITY OF MIAMI   (United States)

^m LERNER RESEARCH INSTITUTE   (United States)

ⁿ UNIVERSITY OF CINCINNATI   (United States)

^o JOHNS HOPKINS UNIVERSITY   (United States)

^p UNIVERSITY OF CHICAGO   (United States)

^q TULANE UNIVERSITY   (United States)

^r UNIVERSITY OF VIRGINIA   (United States)

^s NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; EFAVIRENZ; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BODY MASS; CADAVER DONOR; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIPLE ORGAN FAILURE; ORGAN DONOR; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; RECURRENT INFECTION; SEPSIS; SURVIVAL;

ABDOMEN, ACUTE; ADULT; COINFECTION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84861821680     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23411     Document Type: Article

References (27)

1. Lesens O, Deschênes M, Steben M, Bélanger G, Tsoukas CM,. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection. J Infect Dis 1999; 179: 1254-1258.
2. Weber R, Sabin CA, Friis-MÃ̧ller N, Reiss P, El-Sadr WM, Kirk O, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006; 166: 1632-1641.
3. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008; 8: 355-365.
4. de Vera ME, Dvorchik I, Tom K, Eghtesad B, Thai N, Shakil O, et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant 2006; 6: 2983-2993.
5. Duclos-Vallée JC, Féray C, Sebagh M, Teicher E, Roque-Afonso AM, Roche B, et al.; for THEVIC Study Group. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008; 47: 407-417.
6. Mindikoglu AL, Regev A, Magder LS,. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplantation 2008; 85: 359-368.
7. Vennarecci G, Ettorre GM, Antonini M, Santoro R, Perracchio L, Visco G, Santoro E,. Liver transplantation in HIV-positive patients. Transplant Proc 2007; 39: 1936-1938.
8. Benhamou Y, Di Martino V, Bochet M, Colombet G, Thibault V, Liou A, et al. Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology 2001; 34: 283-287.
9. Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, et al. Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology 2002; 35: 1247-1255.
10. Thein HH, Yi Q, Dore GJ, Krahn MD,. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 2008; 22: 1979-1991.
11. Pineda JA, Romero-Gõmez M, Díaz-García F, Girõn-González JA, Montero JL, Torre-Cisneros J, et al.; for Grupo Andaluz para el Estudio de las Enfermedades Infecciosas and Grupo Andaluz para el Estudio del Hígado. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 2005; 41: 779-789.
12. Aytaman A, Kaufman M, Terrault NA,. Management of posttransplant hepatitis C infection. Curr Opin Organ Transplant 2010; 15: 301-309.
13. Batts KP, Ludwig J,. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-1417.
14. Marcos A, Eghtesad B, Fung JJ, Fontes P, Patel K, Devera M, et al. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation 2004; 78: 966-971.
15. Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997; 92: 1453-1457.
16. Frassetto LA, Browne M, Cheng A, Wolfe AR, Roland ME, Stock PG, et al. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant 2007; 7: 2816-2820.
17. Taga SA, Washington MK, Terrault N, Wright TL, Somberg KA, Ferrell LD,. Cholestatic hepatitis C in liver allografts. Liver Transpl Surg 1998; 4: 304-310.
18. Berenguer M, Aguilera V, Prieto M, Ortiz C, Rodríguez M, Gentili F, et al. Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis. Liver Transpl 2009; 15: 738-746.
19. Lake JR, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Wiesner RH,. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 2005; 5: 549-557.
20. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ,. Liver transplantation in the United States, 1999-2008. Am J Transplant 2010; 10 (pt 2): 1003-1019.
21. Northup PG, Argo CK, Nguyen DT, McBride MA, Kumer SC, Schmitt TM, Pruett TL,. Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis. Transpl Int 2010; 23: 1038-1044.
22. Prieto M, Berenguer M, Rayõn JM, Cõrdoba J, Argüello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999; 29: 250-256.
23. Jain AK, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, et al. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl 2002; 8: 841-845.
24. Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 2010; 363: 2004-2014.
25. Wu Z, Bensinger SJ, Zhang J, Chen C, Yuan X, Huang X, et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 2004; 10: 87-92.
26. Selin LK, Brehm MA, Naumov YN, Cornberg M, Kim SK, Clute SC, Welsh RM,. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol Rev 2006; 211: 164-181.
27. Colloredo G, Guido M, Sonzogni A, Leandro G,. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39: 239-244.